Resident's Forum
RF – Oral Minoxidil for Female Pattern Hair Loss and Other Alopecias
FR – Minoxidil oral para el tratamiento de la alopecia androgénica femenina y otras alopecias
C. Pindado-Ortega
, D. Saceda-Corralo, S. Vañó-Galván
Autor para correspondencia
Servicio de Dermatología, Hospital Ramón y Cajal, Madrid, Spain
Leído
35549
Vecesse ha leído el artículo
2952
Total PDF
32597
Total HTML
Compartir estadísticas
array:24 [ "pii" => "S157821901930304X" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.06.029" "estado" => "S300" "fechaPublicacion" => "2019-12-01" "aid" => "2207" "copyright" => "AEDV" "copyrightAnyo" => "2019" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2019;110:861-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4 "formatos" => array:2 [ "HTML" => 2 "PDF" => 2 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731019301668" "issn" => "00017310" "doi" => "10.1016/j.ad.2018.06.019" "estado" => "S300" "fechaPublicacion" => "2019-12-01" "aid" => "2207" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2019;110:861-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 712 "formatos" => array:2 [ "HTML" => 523 "PDF" => 189 ] ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Foro de Residentes</span>" "titulo" => "FR – Minoxidil oral para el tratamiento de la alopecia androgénica femenina y otras alopecias" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "861" "paginaFinal" => "862" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "RF – Oral Minoxidil for Female Pattern Hair Loss and Other Alopecias" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 708 "Ancho" => 1255 "Tamanyo" => 145540 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A) Mujer de 33 años con alopecia androgénica femenina antes del inicio del tratamiento con minoxidil oral 1<span class="elsevierStyleHsp" style=""></span>mg/día. B) A los 12 meses de tratamiento.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Pindado-Ortega, D. Saceda-Corralo, S. Vañó-Galván" "autores" => array:3 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Pindado-Ortega" ] 1 => array:2 [ "nombre" => "D." "apellidos" => "Saceda-Corralo" ] 2 => array:2 [ "nombre" => "S." "apellidos" => "Vañó-Galván" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S157821901930304X" "doi" => "10.1016/j.adengl.2018.06.029" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901930304X?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019301668?idApp=UINPBA000044" "url" => "/00017310/0000011000000010/v1_201912070749/S0001731019301668/v1_201912070749/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219019303014" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.01.008" "estado" => "S300" "fechaPublicacion" => "2019-12-01" "aid" => "2105" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2019;110:e1-e2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3 "formatos" => array:2 [ "HTML" => 1 "PDF" => 2 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">e-Images in Dermatology</span>" "titulo" => "Squamous Cell Carcinoma on a Port Wine Stain" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e1" "paginaFinal" => "e2" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Carcinoma epidermoide sobre mancha en vino de Oporto" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:6 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 689 "Ancho" => 906 "Tamanyo" => 67971 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "S. Oscoz-Jaime, M. Azcona-Rodríguez, J.I. Yanguas-Bayona" "autores" => array:3 [ 0 => array:2 [ "nombre" => "S." "apellidos" => "Oscoz-Jaime" ] 1 => array:2 [ "nombre" => "M." "apellidos" => "Azcona-Rodríguez" ] 2 => array:2 [ "nombre" => "J.I." "apellidos" => "Yanguas-Bayona" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731018305027" "doi" => "10.1016/j.ad.2018.01.016" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018305027?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019303014?idApp=UINPBA000044" "url" => "/15782190/0000011000000010/v1_201912080808/S1578219019303014/v1_201912080808/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S157821901930294X" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.05.040" "estado" => "S300" "fechaPublicacion" => "2019-12-01" "aid" => "2234" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2019;110:859-60" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3 "formatos" => array:2 [ "HTML" => 1 "PDF" => 2 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case for Diagnosis</span>" "titulo" => "A Nodule on the Breast after Radiation Therapy" "subtitulo" => "[[es]]Nódulo en mama tras radioterapia" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "859" "paginaFinal" => "860" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1610 "Ancho" => 750 "Tamanyo" => 391312 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">B) Hematoxilina-eosina, ×20. C) Hematoxilina-eosina, ×200.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Pindado-Ortega, D. Ortega-Quijano, R. Carrillo-Gijón" "autores" => array:3 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Pindado-Ortega" ] 1 => array:2 [ "nombre" => "D." "apellidos" => "Ortega-Quijano" ] 2 => array:2 [ "nombre" => "R." "apellidos" => "Carrillo-Gijón" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731019302182" "doi" => "10.1016/j.ad.2018.05.023" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019302182?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901930294X?idApp=UINPBA000044" "url" => "/15782190/0000011000000010/v1_201912080808/S157821901930294X/v1_201912080808/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Resident's Forum</span>" "titulo" => "RF – Oral Minoxidil for Female Pattern Hair Loss and Other Alopecias" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "861" "paginaFinal" => "862" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "C. Pindado-Ortega, D. Saceda-Corralo, S. Vañó-Galván" "autores" => array:3 [ 0 => array:4 [ "nombre" => "C." "apellidos" => "Pindado-Ortega" "email" => array:1 [ 0 => "cpindadoortega@gmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "D." "apellidos" => "Saceda-Corralo" ] 2 => array:2 [ "nombre" => "S." "apellidos" => "Vañó-Galván" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Dermatología, Hospital Ramón y Cajal, Madrid, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "FR – Minoxidil oral para el tratamiento de la alopecia androgénica femenina y otras alopecias" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 708 "Ancho" => 1253 "Tamanyo" => 133975 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A, Woman (aged 33 years) with female pattern hair loss before starting oral minoxidil treatment (1 mg/d). B, Patient after 12 months of treatment.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Oral minoxidil (2,4-diamino-6-piperidinopyrimidine-3-oxide) is a potent peripheral vasodilator that was initially used in the 1970s for the treatment of severe refractory hypertension at doses of 10 mg/day to 100 mg/day.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a> Owing to the development of hypertrichosis in a quarter of the patients who received this drug, a topical formulation was developed to treat pattern hair loss, first in men and subsequently in women.</p><p id="par0010" class="elsevierStylePara elsevierViewall">The mechanism of action of minoxidil on the hair follicle is poorly understood. Through the action of its active form, minoxidil sulfate, topical minoxidil shortens the telogen phase and causes resting follicles to prematurely enter the anagen phase. It also prolongs the anagen phase and increases hair follicle size.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> Oral administration reduces blood pressure by inducing relaxation of vascular smooth muscle through the opening of sarcolemmal ATP2-dependent potassium channels. Minoxidil's effect on the hair follicle is also thought to be mediated by minoxidil sulfate-induced opening of potassium channels, although this remains to be demonstrated (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0015" class="elsevierStylePara elsevierViewall">Due to the adverse effects observed at standard doses, oral minoxidil is not widely used for the treatment of alopecia. Evidence indicates that oral minoxidil at low doses (0.5–2.5 mg/d) is beneficial in the treatment of isolated cases of permanent alopecia caused by chemotherapy,<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> chronic telogen effluvium,<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> female pattern hair loss,<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a> and monilethrix.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a> In our experience, oral minoxidil is a particularly interesting option for the treatment of female pattern hair loss and chronic telogen effluvium (1 mg/d) and male pattern hair loss (5 mg/d). It can be administered as monotherapy or in combination with a low-intensity topical minoxidil regimen (e.g. 3 days per week).</p><p id="par0020" class="elsevierStylePara elsevierViewall">The main adverse effect is facial hypertrichosis, the risk of which is dose-dependent (4% risk at 0.25 mg/d, 38% risk at 1 mg/d).<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">4,5</span></a> This adverse effect is reversible upon discontinuation of treatment, and in our experience is generally mild and does not pose a significant problem for the patient. Isolated cases (<2% of patients) of postural hypotension and tachycardia have also been reported,<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a> and therefore measurement of baseline blood pressure is recommended. In patients with blood pressure values <90/60 mmHg and those with postural hypotension  sodium chloride (50 mg) should be added to the formulation.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a> In our professional experience doses of 1 mg/day are safe and rarely cause hypotension.</p><p id="par0025" class="elsevierStylePara elsevierViewall">In Spain, oral minoxidil is sold as 10-mg tablets for the treatment of severe arterial hypertension, but it can be formulated in capsules. In patients with female pattern hair loss the addition of spironolactone (25 mg) reduces the risk of edema in the lower limbs and potentiates the therapeutic effects of minoxidil, although theoretically spironolactone can worsen postural hypotension.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">In conclusion, oral minoxidil at low doses is an interesting therapeutic alternative in patients who decline or do not tolerate topical administration, especially in cases of female pattern hair loss.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1177565" "palabras" => array:3 [ 0 => "Minoxidil" 1 => "Alopecia" 2 => "Trichology" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Pindado-Ortega C, Saceda-Corralo D, Vañó-Galván S. FR – Minoxidil oral para el tratamiento de la alopecia androgénica femenina y otras alopecias. Actas Dermosifiliogr. 2019;110:861–862.</p>" ] ] "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 708 "Ancho" => 1253 "Tamanyo" => 133975 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A, Woman (aged 33 years) with female pattern hair loss before starting oral minoxidil treatment (1 mg/d). B, Patient after 12 months of treatment.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Minoxidil: Mechanisms of action on hair growth" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A.G. Messenger" 1 => "J. Rundegren" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2133.2004.05785.x" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2004" "volumen" => "150" "paginaInicial" => "186" "paginaFinal" => "194" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14996087" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of permanent chemotherapy-induced alopecia with low dose oral minoxidil" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "X. Yang" 1 => "K.-E. Thai" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ajd.12350" "Revista" => array:6 [ "tituloSerie" => "Australas J Dermatol" "fecha" => "2016" "volumen" => "57" "paginaInicial" => "e130" "paginaFinal" => "e132" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25966934" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "E. Perera" 1 => "R. Sinclair" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.12688/f1000research.11775.1" "Revista" => array:5 [ "tituloSerie" => "F1000Res" "fecha" => "2017" "volumen" => "6" "paginaInicial" => "1650" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29167734" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Female pattern hair loss: A pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R.D. Sinclair" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ijd.13838" "Revista" => array:6 [ "tituloSerie" => "Int J Dermatol" "fecha" => "2018" "volumen" => "57" "paginaInicial" => "104" "paginaFinal" => "109" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29231239" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of monilethrix with oral minoxidil" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R. Sinclair" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jdcr.2016.02.011" "Revista" => array:6 [ "tituloSerie" => "JAAD Case Rep" "fecha" => "2016" "volumen" => "2" "paginaInicial" => "212" "paginaFinal" => "215" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27284572" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000011000000010/v1_201912080808/S157821901930304X/v1_201912080808/en/main.assets" "Apartado" => array:4 [ "identificador" => "34945" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Resident's Forum" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011000000010/v1_201912080808/S157821901930304X/v1_201912080808/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901930304X?idApp=UINPBA000044" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Noviembre | 27 | 13 | 40 |
| 2024 Octubre | 230 | 70 | 300 |
| 2024 Septiembre | 330 | 56 | 386 |
| 2024 Agosto | 375 | 80 | 455 |
| 2024 Julio | 369 | 69 | 438 |
| 2024 Junio | 326 | 82 | 408 |
| 2024 Mayo | 334 | 48 | 382 |
| 2024 Abril | 272 | 48 | 320 |
| 2024 Marzo | 363 | 49 | 412 |
| 2024 Febrero | 615 | 44 | 659 |
| 2024 Enero | 804 | 51 | 855 |
| 2023 Diciembre | 683 | 44 | 727 |
| 2023 Noviembre | 950 | 54 | 1004 |
| 2023 Octubre | 966 | 56 | 1022 |
| 2023 Septiembre | 858 | 61 | 919 |
| 2023 Agosto | 671 | 31 | 702 |
| 2023 Julio | 667 | 61 | 728 |
| 2023 Junio | 623 | 50 | 673 |
| 2023 Mayo | 714 | 65 | 779 |
| 2023 Abril | 583 | 41 | 624 |
| 2023 Marzo | 607 | 46 | 653 |
| 2023 Febrero | 658 | 68 | 726 |
| 2023 Enero | 777 | 68 | 845 |
| 2022 Diciembre | 590 | 56 | 646 |
| 2022 Noviembre | 812 | 56 | 868 |
| 2022 Octubre | 970 | 52 | 1022 |
| 2022 Septiembre | 1217 | 71 | 1288 |
| 2022 Agosto | 1805 | 75 | 1880 |
| 2022 Julio | 369 | 70 | 439 |
| 2022 Junio | 202 | 49 | 251 |
| 2022 Mayo | 698 | 63 | 761 |
| 2022 Abril | 947 | 47 | 994 |
| 2022 Marzo | 1045 | 88 | 1133 |
| 2022 Febrero | 922 | 50 | 972 |
| 2022 Enero | 883 | 57 | 940 |
| 2021 Diciembre | 743 | 54 | 797 |
| 2021 Noviembre | 695 | 66 | 761 |
| 2021 Octubre | 891 | 88 | 979 |
| 2021 Septiembre | 597 | 52 | 649 |
| 2021 Agosto | 659 | 48 | 707 |
| 2021 Julio | 659 | 26 | 685 |
| 2021 Junio | 750 | 49 | 799 |
| 2021 Mayo | 652 | 65 | 717 |
| 2021 Abril | 1329 | 111 | 1440 |
| 2021 Marzo | 661 | 50 | 711 |
| 2021 Febrero | 329 | 38 | 367 |
| 2021 Enero | 394 | 54 | 448 |
| 2020 Diciembre | 284 | 24 | 308 |
| 2020 Noviembre | 184 | 20 | 204 |
| 2020 Octubre | 100 | 20 | 120 |
| 2020 Septiembre | 81 | 20 | 101 |
| 2020 Agosto | 69 | 33 | 102 |
| 2020 Julio | 43 | 25 | 68 |
| 2020 Junio | 64 | 30 | 94 |
| 2020 Mayo | 46 | 30 | 76 |
| 2020 Abril | 45 | 31 | 76 |
| 2020 Marzo | 51 | 22 | 73 |
| 2020 Febrero | 7 | 5 | 12 |
| 2020 Enero | 2 | 2 | 4 |
Mostrar todo
